Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy

Natalizumab, a highly effective therapy for relapsing-remitting multiple sclerosis, is associated with a risk of progressive multifocal leukoencephalopathy (PML). The objective of this analysis was to examine factors predicting survival in a large natalizumab-associated PML global population. Patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong-Si, Tuan, Gheuens, Sarah, Gangadharan, Amy, Wenten, Made, Philip, Jeffrey, McIninch, James, Datta, Shoibal, Richert, Nancy, Bozic, Carmen, Bloomgren, Gary, Richman, Sandra, Weber, Thomas, Clifford, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628054/
https://www.ncbi.nlm.nih.gov/pubmed/25771865
http://dx.doi.org/10.1007/s13365-015-0316-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628054/
https://www.ncbi.nlm.nih.gov/pubmed/25771865
http://dx.doi.org/10.1007/s13365-015-0316-4

Ejemplares similares